Regeneron drug halves muscle loss in combination with Novo's semaglutide in trial

An experimental weight-loss drug being developed by Regeneron used in combination with Novo Nordisk's semaglutide reduced the loss of muscle mass by 50% compared with the loss seen with semaglutide al...

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。